184
Participants
Start Date
December 19, 2019
Primary Completion Date
December 20, 2025
Study Completion Date
December 20, 2025
Doxazosin
16 mg or maximum tolerated dose (MTD)
Placebo
Matching placebo
RECRUITING
Brown University, Providence
Lead Sponsor
Brown University
OTHER